Cronos Group (NASDAQ:CRON) Posts Earnings Results, Hits Estimates

Posted by on May 11th, 2026

Cronos Group (NASDAQ:CRON – Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.01 EPS for the quarter, hitting analysts’ consensus estimates of $0.01, Zacks reports. Cronos Group had a negative net margin of 6.44% and a negative return on equity of 1.12%.

Here are the key takeaways from Cronos Group’s conference call:

  • Record financial performance: Cronos reported Q1 net revenue of CAD 45.2M (+40% YoY) and record gross profit of CAD 19.2M (+39% YoY) with adjusted EBITDA of CAD 5.1M, the second-highest in company history.
  • Spinach market leadership: The Spinach brand captured #1 positions in vapes (9.8% total vape share and 11.1% cartridge share) and edibles (20.8% total, gummies 22.7%), with PUFFERZ reaching #2 in all-in-one vapes just four months after launch.
  • Strong international momentum and M&A: Cronos Israel grew 53% YoY (ninth consecutive record quarter) and other international markets grew 97% YoY, and management expects the CanAdelaar acquisition (Netherlands market leader) to close in summer 2026 to scale its European footprint.
  • Robust balance sheet and capital return: The company has no debt, CAD 822M in cash and equivalents, and the board authorized a renewed CAD 50M share repurchase program to deploy capital across growth, buybacks, and M&A.
  • Cost and timing pressures: Operating expenses rose to CAD 20.5M (up CAD 3.3M YoY) partly due to CanAdelaar transaction costs, cash decreased CAD 10M in the quarter after CAD 17M of repurchases, and the CanAdelaar long-stop date was extended as a precaution, introducing execution and timing risk.

Cronos Group Stock Performance

Cronos Group stock traded up $0.17 during midday trading on Monday, hitting $2.71. 2,947,806 shares of the company’s stock were exchanged, compared to its average volume of 1,407,457. Cronos Group has a 12 month low of $1.84 and a 12 month high of $3.43. The firm has a 50-day moving average of $2.59 and a two-hundred day moving average of $2.60. The company has a market cap of $1.02 billion, a PE ratio of -270.23 and a beta of 0.87.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Weiss Ratings cut shares of Cronos Group from a “hold (c)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. Wall Street Zen upgraded shares of Cronos Group from a “sell” rating to a “hold” rating in a report on Sunday, March 8th. Canaccord Genuity Group assumed coverage on shares of Cronos Group in a report on Tuesday, January 27th. They issued a “buy” rating on the stock. Sanford C. Bernstein restated a “market perform” rating and issued a $2.30 price target on shares of Cronos Group in a report on Wednesday, January 14th. Finally, TD Securities began coverage on shares of Cronos Group in a report on Tuesday, February 24th. They set a “buy” rating on the stock. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $2.30.

Get Our Latest Research Report on Cronos Group

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc grew its holdings in Cronos Group by 16.1% during the 2nd quarter. Legal & General Group Plc now owns 195,368 shares of the company’s stock worth $374,000 after acquiring an additional 27,111 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in shares of Cronos Group by 35.0% in the 2nd quarter. Corient Private Wealth LLC now owns 135,882 shares of the company’s stock valued at $260,000 after buying an additional 35,245 shares in the last quarter. Bank of America Corp DE boosted its holdings in shares of Cronos Group by 11.0% in the 2nd quarter. Bank of America Corp DE now owns 135,180 shares of the company’s stock valued at $258,000 after buying an additional 13,450 shares in the last quarter. Headlands Technologies LLC boosted its holdings in shares of Cronos Group by 12.5% in the 4th quarter. Headlands Technologies LLC now owns 63,097 shares of the company’s stock valued at $166,000 after buying an additional 6,998 shares in the last quarter. Finally, Virtu Financial LLC boosted its holdings in shares of Cronos Group by 10.4% in the 4th quarter. Virtu Financial LLC now owns 52,852 shares of the company’s stock valued at $139,000 after buying an additional 4,990 shares in the last quarter. 8.71% of the stock is currently owned by institutional investors.

About Cronos Group

(Get Free Report)

Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. Headquartered in Toronto, Ontario, the company manages operations that span the full cannabis value chain, including breeding, greenhouse cultivation, extraction, product formulation and packaging. Cronos Group’s business model emphasizes innovation in product development and scalability in manufacturing to meet evolving regulatory and consumer demands.

The company’s branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.

Featured Articles

Earnings History for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.